Hepatitis SA, Adelaide, 2024. 3p.
This article has information about the affect of the virus, how it is transmitted and how it can be prevented or treated.
National Drug & Alcohol Research Centre (NDARC), Sydney 2024. 140p. report; infographic, summary, background and methods
The EDRS comprises a sentinel sample of people who regularly use ecstasy and/or other illicit stimulants, recruited via social media and word-of-mouth across each capital city of Australia.
National Drug & Alcohol Research Centre (NDARC), Sydney 2024. 128p. report; infographic; summary; background and methods.
A sentinel sample of people who regularly inject illicit drugs, recruited via advertisements in needle syringe programs and other harm reduction services, as well as via peer referral, across each capital city of Australia.
Pathology Tests Explained Ltd (PTEx), Sydney, 2023. 6p.
Explains what is being tested, when tests might be requested and what the results mean. Includes common questions about transmission, periods of contagion, and prevention/vaccination.
Aust. Govt. Dept. of Health and Aged Care, Canberra, 2023. 3p.
Information about hepatitis A vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the hepatitis A vaccine free under the National Immunisation Program.
BMC Public Health (via Springer Nature), London, 2024. 13p.
The findings of this study advocate for the development and implementation of integrated care models that are responsive to the specific challenges and preferences of affected mothers.
NDARC, Sydney, 2024. 9p.
Examines demographic and drug use profile of groups with different patterns of sexual engagement; and whether these patterns are associated with sexual and broader risk factors.
BMC Infectious Diseases via Springer Nature, London, 2024. 9p.
This study aims to analyze whether undergoing amniocentesis during pregnancy in women diagnosed with hepatitis B virus (HBV) infection leads to HBV transmission to newborns.
BMC Infectious Diseases, London, 2024. 9p.
Results indicate that health, education drug treatment and rehab programs, should all be developed for this high-risk group to prevent HCV acquisition and transmission.
Current Health Sciences Journal, Vol. 40 (2), 2014. 4p.
The prevalence rate of chronic hepatitis C infection at patients with severe mental illness can be nine times higher than in healthy population. Patients with psychiatric affections (especially institutionalized people) have generally a higher risk of being infected with virus B in comparison with general population.
Harm Reduction Journal via BMC Springer Nature, London, 2024. 19p.
Examines how ED staff experience opioid-specific harm reduction provision and engage in harm reduction practice, including potential facilitators and barriers to engagement.
Hepatitis Australia, Canberra. Website.
Information about the free online or phone service for anyone in Australia to talk about viral hepatitis (including hep A,B,C, D) providing information and support (including peer support), referrals, advocacy, and workforce support.
Poche Centre for Indigenous Health, Brisbane, 2024. Videos
For those working with young Aboriginal and Torres Strait Islander peoples in remote communities. Hear from health workers and researchers, supporting LGBTQIA+ youth, and: STI and BBV testing.
University of Sydney, Sydney, 2024. 57min Webinar; 77p. handout
Dr Eddie Mullen discusses: substance use and addictive behaviours with a developmental perspective; the impact of substance use in Neurodiversity, and reflects on opportunities and challenges for clinicians and services.
Hepatitis SA, Adelaide, 2024. 5p. article.
Changes to Australia’s migration laws have lowered the barriers to permanent residency for people living with hepatitis B. These changes come after years of lobbying by advocacy groups. Contains links to source articles and videos.
MDPI, Basel. 2024. 12p.
Demonstrates that mothers in recovery are still stigmatised often resulting in disengagement or reluctance to access healthcare settings.
Health+Law Research Partnership, Sydney, 2024. 53:35 minute video, plus transcript.
An introduction to Australian migration law in the context of hep B, providing practical information for those migrating as well as for clinicians, peers and others who work with people in the process of migrating to Australia.
Health+Law Research Partnership, Sydney, 2024. 1 hour video plus transcript
Speakers discuss and answer questions about hep B, migrating to Australia and migration law as well as the migration process for someone living with hep B, and how clinicians can support better migration outcomes for their patients.
Faculty of Law, Uni of Sydney, Sydney, 2023. Video 1:24 hours plus transcript.
Clinicians, support workers, peers and lawyers are often asked to support individuals living with a BBV through various legal processes, but what do these look like? How are they changing? What is the impact, and which are their priorities?
Journal of Viral Hepatitis, London, 2023. 14p.
Demonstrates high HCV transmission risk in prison, particularly among people injecting drugs. Improved OAT coverage and needle/syringe programmes to reduce sharing injecting equipment are required.
National Indigenous Times, Perth, 2024. 3p.
Only 42% of peoples living with hep B remained in medical care after diagnosis and 38% received guideline-recommended medical care. The only independent factor was their Indigenous status.
Hep C U Later (NHS), England, 2024. 5p. Blog post.
Explores some of the barriers to engagement in testing, referrals to treatment, medication and follow-up post treatment completion for those affected by homelessness or unstable housing.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.